Glupast Tablet 10mg (Mitiglinide Calcium Hydrate)

Adult dose

In adults, this medicine is administered orally as monotherapy or in combination therapy at a dose of 10mg of mitiglinide calcium hydrate per dose, 3 times daily immediately before each meal. Adjust the dose appropriately according to symptoms.

This medication lowers blood sugar, which can cause symptoms of hypoglycemia, a condition where blood sugar drops too low. The risk of hypoglycemia may increase when used with other blood glucose-lowering agents, so caution is needed. This medication is not suitable for patients with severe ketosis, diabetic coma, or insulin-dependent diabetes. It is also not recommended for patients with severe infections, pre/post-surgery, or major injuries. Patients with allergies to the medication’s ingredients, pregnant women, or women who may become pregnant should not use this medication. Patients with genetic lactose intolerance should also refrain from taking this medication. Those with liver or kidney impairment may have increased risk of hypoglycemia and should use this medication with caution. Patients using insulin preparations should also be cautious. Older adults, those with heart disease, pituitary or adrenal dysfunction, gastrointestinal disorders, poor nutritional status, vigorous exercise, or excessive alcohol consumption may have increased risk of hypoglycemia. During treatment, symptoms of hypoglycemia such as dizziness, trembling, cold sweats, and fatigue may occur; sugar should be consumed immediately if symptoms arise. Especially, when taken with α-glucosidase inhibitors, consuming glucose is more effective. This medication should be taken right before meals to maximize its effect; taking it after meals may reduce its effectiveness. Blood sugar levels should be regularly monitored, and if symptoms do not improve, patients should consult healthcare professionals. Additionally, this medication can interact with various other drugs, so if patients are taking other medications, they must inform their doctor or pharmacist. For older adults, treatment should start at a lower dose, and their condition should be closely monitored. Pregnant or breastfeeding women should not use this medication, and its safety in children has not been established. When storing the medication, keep it out of reach of children and store it at room temperature without transferring it to another container.

• Hypoglycemic symptoms
• weight gain
• edema
• abdominal distension
• constipation
• elevated BNP
• elevated pyruvate
• elevated γ-GTP
• elevated CK (CPK)
• elevated lactate

This medication should be stored in a sealed container to protect it from air and moisture. Additionally, it is best stored at room temperature between 1°C and 30°C.

Appearance

White, rectangular tablet

Package unit

90 tablets (10 tablets/PTP packaging x 9 pieces)